OCGN is at a nice entry point. missed a couple chances to scalp but its set to go up considerably. for reference theyre a pennsylvania based biotech company with distribution deal with bharat biotech for covid vaccine covaxin, phase 3 interim data just came out yesterday with 81% efficacy, safe...